Search research articles
Contact Us
Filters
Showing results (181-190 of 242) with videos related to
Page
of 25
Sort By:
Travel Medicine and Infectious Disease
|
August 7, 2022
Malaria in long-term travelers: Infection risks and adherence to preventive measures - A prospective cohort study
Franciska S T Suryapranata, Femke W Overbosch, Amy Matser, et al.
Journal of Global Antimicrobial Resistance
|
December 16, 2022
Erratum to 'In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum' [Journal of Global Antimicrobial Resistance 24 (2021) 93-97]
Erik Koehne, Andrea Kreidenweiss, Bayode Romeo Adegbite, et al.
Veterinary Dermatology
|
December 16, 2015
IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
Andrea J Gonzales, Timothy J Fleck, William R Humphrey, et al.
Clinical Child and Family Psychology Review
|
September 10, 2018
Early Caregiver-Child Interaction and Children's Development: Lessons from the St. Petersburg-USA Orphanage Intervention Research Project
Robert B McCall, Christina J Groark, Brandi N Hawk, et al.
The Netherlands Journal of Medicine
|
October 6, 2004
Ocular syphilis acquired through oral sex in two HIV-infected patients
M B B McCall, J J C van Lith-Verhoeven, R van Crevel, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Cephalalgia : an International Journal of Headache
|
December 18, 2002
Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633
R B McCall, R Huff, C L Chio, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist
R B McCall, A G Romero, M J Bienkowski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 26, 2023
Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022
Carsten van Rossum, Corianne Meijer, Ingrid Jm van Weerdenburg, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 242) with videos related to
Sort By:
Page
of 25
Travel Medicine and Infectious Disease
|
August 7, 2022
Malaria in long-term travelers: Infection risks and adherence to preventive measures - A prospective cohort study
Franciska S T Suryapranata, Femke W Overbosch, Amy Matser, et al.
Journal of Global Antimicrobial Resistance
|
December 16, 2022
Erratum to 'In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum' [Journal of Global Antimicrobial Resistance 24 (2021) 93-97]
Erik Koehne, Andrea Kreidenweiss, Bayode Romeo Adegbite, et al.
Veterinary Dermatology
|
December 16, 2015
IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
Andrea J Gonzales, Timothy J Fleck, William R Humphrey, et al.
Clinical Child and Family Psychology Review
|
September 10, 2018
Early Caregiver-Child Interaction and Children's Development: Lessons from the St. Petersburg-USA Orphanage Intervention Research Project
Robert B McCall, Christina J Groark, Brandi N Hawk, et al.
The Netherlands Journal of Medicine
|
October 6, 2004
Ocular syphilis acquired through oral sex in two HIV-infected patients
M B B McCall, J J C van Lith-Verhoeven, R van Crevel, et al.
Journal of Medicinal Chemistry
|
April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives
C H Lin, S R Haadsma-Svensson, R A Lahti, et al.
Cephalalgia : an International Journal of Headache
|
December 18, 2002
Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633
R B McCall, R Huff, C L Chio, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability
C H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist
R B McCall, A G Romero, M J Bienkowski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 26, 2023
Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022
Carsten van Rossum, Corianne Meijer, Ingrid Jm van Weerdenburg, et al.
Page
of 25